Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Milk minerals are a natural mineral complex derived from milk, primarily composed of calcium phosphate along with magnesium, potassium, and phosphorus. Developed and manufactured by Arla Foods Ingredients (specifically under the brand name Capolac), these minerals are studied for their metabolic effects, particularly their ability to stimulate the secretion of gut hormones such as glucagon-like peptide-1 (GLP-1) and peptide tyrosine-tyrosine (PYY). The mechanism involves the activation of the calcium-sensing receptor (CaSR) on intestinal L-cells, which acts synergistically with dietary proteins to enhance incretin release. Clinical research indicates that milk minerals may play a role in appetite suppression, increasing energy expenditure, and improving postprandial glucose metabolism, making them a candidate for the management of obesity and metabolic disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on milk minerals.